Status:
COMPLETED
Budd-Chiari Syndrome in China: Balloon Angioplasty Alone or Combined With Stent Placement?
Lead Sponsor:
Air Force Military Medical University, China
Conditions:
Budd-Chiari Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Budd-Chiari syndrome (BCS) is defined as the hepatic outflow obstruction from the small hepatic veins to the confluence between inferior vena cava and right atrium, which often leads to the life-threa...
Eligibility Criteria
Inclusion
- Informed consent.
- Age 18-75 years old.
- Budd-Chiari syndrome
- Child-Pugh score \<13 points.
- Eligible for percutaneous recanalization.
Exclusion
- Pregnancy or lactation.
- Malignancy.
- HIV infection.
- Severe cardiac or lung diseases.
- Severe renal dysfunction (serum\> 265.2 umol/l).
- Uncontrolled systemic infection.
- Allergic to contrast agents.
- Poor compliance.
- A prior history of percutaneous recanalization.
- Ineligible for percutaneous recanalization.
- Liver cirrhosis with severe portal hypertension-related complications.
- Acute liver failure.
- Progressive deterioration of liver function.
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT02201485
Start Date
May 1 2014
End Date
April 1 2019
Last Update
April 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital of Digestive Diseases
Xi’an, Shanxi, China, 710032